Agilent Presents Thought Leader Award to Professor Hualiang Jiang Chinese Academy of Sciences scientist recognized for his work in medicinal chemistry and drug discovery SANTA CLARA, Calif., September 19, 2019 Agilent Technologies Inc. (NYSE: A) announced today that Professor Hualiang Jiang has received an Agilent Thought Leader Award. Professor Jiang directs the Shanghai Institute of... Read more
Basel, 19 September 2019 Roche renews its commitment to the primary healthcare Phelophepa trains, marking the 25th anniversary Roche and Transnet, the main freight logistics company in South Africa, came together in 1994 to establish Phelophepa, the world’s first comprehensive primary healthcare facility on rail Phelophepa has touched the lives of over 14 million people... Read more
BREA, Calif., Sept. 17, 2019 /PRNewswire/ — Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), announced today the pricing of its initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. The shares are expected to begin trading on the New York Stock... Read more
Germantown, Maryland, and Hilden, Germany, September 16, 2019 – QIAGEN today announced the winners of its first Young Investigator Award competition for outstanding researchers in forensic science. The 2019 award winner and two runners-up were recognized during the International Society for Forensic Genetics (ISFG) Congress in Prague. The 2019 Young Investigator Award was awarded to... Read more
Basel, 16 September 2019 Roche ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Indices for the eleventh year running Roche ranked second in the 2019 Dow Jones Sustainability Indices The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy Compared to 2018 Roche significantly... Read more
Basel, 16 September 2019 Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients cobas pro integrated solutions improves productivity in the lab and enhances reliability and turnaround times in delivering results to patients By simplifying operations in the lab, Roche is in-turn helping physicians provide evidence-based... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Sep. 13, 2019– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it is giving notice of the redemption of all of its outstanding 5% Senior Unsecured Notes due in 2021 (the “2021 Notes”). In accordance with the terms of the indenture governing the 2021... Read more
Basel, 13 September 2019 Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis Post-hoc analysis from a Phase III open-label extension study showed a 42 percent reduction in the risk of PPMS patients needing a wheelchair after 6.5 years of OCREVUS treatment... Read more
Basel, 13 September 2019 Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer New fixed-dose combination is administered under the skin in just minutes, significantly reducing the time spent receiving treatment Data will be submitted to health authorities around the world, including the... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (“Illumina”) (NASDAQ: ILMN) has been notified of an unsolicited “mini-tender offer” by TRC Capital Corporation (“TRC”) to purchase up to 500,000 shares of Illumina common stock at a price of $268.80 per share in cash. TRC’s offer is subject to a number of conditions, including TRC’s ability to obtain sufficient financing.... Read more